[PERSON]
Arvind Chopra
Featured in 1 tracked story · first seen
Situations
Ashwagandha clinical safety studies
2 clusters · 3 sources · last updated
Latest: Ashwagandha study finds no liver or kidney damage
A large-scale, multicentre, randomized, double-blind, placebo-controlled clinical trial conducted in India has reported that daily administration of a standardized Ashwagandha root extract is well tolerated over a 24-wee